Miranda Edward P, Bellevue Oliver C, Leong Stanley P L
Center for Complex Reconstruction, San Francisco, Calif ; Center for Melanoma Research and Treatment, Department of Surgery, California Pacific Medical Center, San Francisco, Calif.
School of Medicine, University of California San Francisco.
Eplasty. 2014 Sep 12;14:e32. eCollection 2014.
The rising incidence of melanoma and the high prevalence of breast cancer have generated a new scientific problem-how do the regional lymph node basins function after radical lymphadenectomy and are lymphatic drainage patterns altered after radical lymphadenectomy? Furthermore, after radical lymphadenectomy, selective sentinel lymphadenectomy is still a technically feasible and valid staging tool in the upper extremity? Thus, our study asks if selective sentinel lymph node dissection is technically feasible after radical lymph node dissection of the regional draining basin of the upper extremity (axilla).
Retrospective review of a prospectively maintained database of patients was reviewed to identify patients who had lymphoscintigraphy and sentinel lymph node biopsy of the upper extremity after a radical axillary node dissection procedure. Imaging and pathology results were analyzed.
Seven patients fulfilling the inclusion criteria were identified. The patients all had either melanoma or invasive squamous cell carcinoma, and sentinel lymph nodes were identified in 6 out of 7 patients. One patient had metastases to 2 sentinel lymph nodes. Alternative drainage pathways were identified in 29% of patients, and 14% of patients had no identifiable drainage basin on lymphoscintigraphy.
Sentinel lymph node dissection is technically feasible after previous axillary dissection. Lymphoscintigraphy is an important perioperative tool as lymphatic drainage may be altered or not observed as evidenced in 43% of the studied patients. However, when lymphatic drainage is detected by lymphoscintigraphy, pathologically significant sentinel lymph nodes are surgically identifiable.
黑色素瘤发病率的上升以及乳腺癌的高患病率引发了一个新的科学问题——根治性淋巴结清扫术后区域淋巴结引流区的功能如何,根治性淋巴结清扫术后淋巴引流模式是否会改变?此外,在上肢,根治性淋巴结清扫术后选择性前哨淋巴结清扫是否仍是一种技术上可行且有效的分期工具?因此,我们的研究探讨了在上肢(腋窝)区域引流区进行根治性淋巴结清扫术后,选择性前哨淋巴结清扫在技术上是否可行。
回顾性分析一个前瞻性维护的患者数据库,以确定在根治性腋窝淋巴结清扫术后接受上肢淋巴闪烁显像和前哨淋巴结活检的患者。对影像和病理结果进行分析。
确定了7名符合纳入标准的患者。所有患者均患有黑色素瘤或浸润性鳞状细胞癌,7名患者中有6名发现了前哨淋巴结。1名患者的2个前哨淋巴结有转移。29%的患者发现了替代引流途径,14%的患者在淋巴闪烁显像中未发现可识别的引流区。
在先前腋窝清扫术后,前哨淋巴结清扫在技术上是可行的。淋巴闪烁显像术是一种重要的围手术期工具,因为在43%的研究患者中证实淋巴引流可能会改变或未被观察到。然而,当通过淋巴闪烁显像术检测到淋巴引流时,具有病理意义的前哨淋巴结在手术中是可识别的。